Stock Analiz

IceCure Medical Ltd. ICCM

Medical/Dental Instruments · data as of November 13, 2026

$0.73Market cap $3M
Open the interactive analysis →

IceCure Medical Ltd. (ICCM) is a healthcare company listed in the US with a market value of about $3M. In fiscal year 2025 it had revenue of $3M and net income of -$15M, a net margin of -445.6%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of -3% a year, a 5-year average ROIC of -94%.

About IceCure Medical

IceCure Medical is listed in the US and classified in medical/dental instruments. Revenue went from $2M in 2019 to $3M in 2025, growth of about 13.0% a year. It was profitable in 0 of the last 7 years in our data. It spends 220% of revenue on research and development.

Score: 0.8 / 5

Value0/5
Future growth2/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.7
P/B0.3
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-584.1%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)2.7%
Revenue growth (5 yrs, per year)-2.7%
EPS growth (5 yrs, per year)1.8%
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-430.9%
ROIC (5-yr avg.)-93.5%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 7 years

Fiscal year2025202420232022202120202019
Revenue$3M$3M$3M$3M$4M$4M$2M
Net income-$15M-$15M-$15M-$17M-$10M-$4M-$5M
Free cash flow-$15M-$13M-$13M-$15M-$13M-$4M-$2M
EPS (diluted)$-4.39$-4.47$-4.28$-4.96$-2.89$-1.09$-1.33
Net margin-445.6%-465.4%-453.8%-550.3%-239.1%-96.4%-279.7%
ROIC-128.5%-164.9%-96.4%-50.8%-27.0%-48.6%-114.8%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does IceCure Medical pay a dividend?

Not currently.

Is IceCure Medical a good stock to buy?

We do not give buy or sell advice. IceCure Medical scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.